Highlights From PFE's Q4 Conference Call: Wyeth Integration Going Well; Issues Guidance Through 2012
Tweet Send to a Friend
Pfizer (NYSE: PFE) reports Q4 EPS of $0.49, versus the analyst estimate of $0.50. Revenue for the quarter was $16.54 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
